Details
Stereochemistry | RACEMIC |
Molecular Formula | C15H22N2O |
Molecular Weight | 246.348 |
Optical Activity | ( + / - ) |
Defined Stereocenters | 2 / 2 |
E/Z Centers | 0 |
Charge | 0 |
SHOW SMILES / InChI
SMILES
[H][C@@]12CCN(C)C[C@@]1([H])C(=O)C3=C(C2)NC(C)=C3CC
InChI
InChIKey=PVZMYDPRVUCJKV-CMPLNLGQSA-N
InChI=1S/C15H22N2O/c1-4-11-9(2)16-13-7-10-5-6-17(3)8-12(10)15(18)14(11)13/h10,12,16H,4-8H2,1-3H3/t10-,12+/m0/s1
Piquindone is an antipsychotic pyrroloisoquinoline derivative that binds to dopamine D2 receptors. It is a potent D-2 antagonist. It has a low potential for extrapyramidal effects and tardive dyskinesia. Piquindone exhibited relatively weaker cataleptogenic and antistereotypic activity than haloperidol, and had minimal activity in a rat chronic stereotypy model of receptor supersensitivity. Piquindone almost as potent as haloperidol, with fewer or less intense extrapyramidal effects and low potential for tardive dyskinesia. Piquindone led to moderate but significant improvements in the positive symptoms of schizophrenia and to improvements in negative symptoms just below the level of statistical significance. Therapeutic efficacy of a piquindone antagonist in Tourette Syndrome can be achieved without production of disabling extrapyramidal-side effects.
Approval Year
PubMed
Title | Date | PubMed |
---|---|---|
Improvement of symptoms in Tourette syndrome by piquindone, a novel dopamine-2 receptor antagonist. | 1986 Jul |
|
Locomotor behaviors in response to new selective D-1 and D-2 dopamine receptor agonists, and the influence of selective antagonists. | 1986 Jul |
|
The thermodynamics of agonist and antagonist binding to dopamine D-2 receptors. | 1986 Sep |
|
Effects of D2-dopaminergic receptor stimulation on male rat sexual behavior. | 1987 |
|
The dopamine D-2 antagonist, Ro 22-1319, inhibits the persistent behavioral syndrome induced by iminodipropionitrile (IDPN) in mice. | 1987 Jun |
|
Further evidence for two directions of D-1:D-2 dopamine receptor interaction revealed concurrently in distinct elements of typical and atypical behaviour: studies with the new enantioselective D-2 agonist LY 163502. | 1989 |
|
Comparison of prolactin responses to D-1 and D-2 antagonists in rats: Ro 22-1319 is a potent D-2 antagonist. | 1989 Feb 15 |
|
The induction of grooming and vacuous chewing by a series of selective D-1 dopamine receptor agonists: two directions of D-1:D-2 interaction. | 1989 Feb 7 |
|
Alterations in sleep polygraphy after neuroleptic withdrawal: a putative supersensitive dopaminergic mechanism. | 1989 Jan |
|
Stereoelectronic study of zetidoline, a dopamine D2 receptor antagonist. | 1989 Jan |
|
Structural requirements of Na+-dependent antidopaminergic agents: Tropapride, Piquindone, Zetidoline, and Metoclopramide. Comparison with Na+-independent ligands. | 1989 Mar |
|
The effect of dopamine receptor blockade on the development of sensitization to the locomotor activating effects of amphetamine and morphine. | 1989 Oct 9 |
|
Optically active benzamides as predictive tools for mapping the dopamine D2 receptor. | 1990 Jul 31 |
|
Dopamine D2 receptor model explains binding affinity of neuroleptics: piquindone and its structure activity relationships. | 1996 Apr |
|
The incorporation of butyrophenones and related compounds into a pharmacophore for dopamine D2 antagonists. | 1997 Aug |
|
A multiway 3D QSAR analysis of a series of (S)-N-[(1-ethyl-2-pyrrolidinyl)methyl]-6-methoxybenzamides. | 1998 Jan |
|
Pharmacological options for the treatment of Tourette's disorder. | 2001 |
Name | Type | Language | ||
---|---|---|---|---|
|
Official Name | English | ||
|
Code | English | ||
|
Common Name | English | ||
|
Common Name | English | ||
|
Code | English | ||
|
Common Name | English |
Code System | Code | Type | Description | ||
---|---|---|---|---|---|
|
C032412
Created by
admin on Fri Dec 15 17:15:04 GMT 2023 , Edited by admin on Fri Dec 15 17:15:04 GMT 2023
|
PRIMARY | |||
|
C174777
Created by
admin on Fri Dec 15 17:15:04 GMT 2023 , Edited by admin on Fri Dec 15 17:15:04 GMT 2023
|
PRIMARY | |||
|
CHEMBL1192678
Created by
admin on Fri Dec 15 17:15:04 GMT 2023 , Edited by admin on Fri Dec 15 17:15:04 GMT 2023
|
PRIMARY | |||
|
DTXSID70101649
Created by
admin on Fri Dec 15 17:15:04 GMT 2023 , Edited by admin on Fri Dec 15 17:15:04 GMT 2023
|
PRIMARY | |||
|
5573
Created by
admin on Fri Dec 15 17:15:04 GMT 2023 , Edited by admin on Fri Dec 15 17:15:04 GMT 2023
|
PRIMARY | |||
|
O1C9WXY65C
Created by
admin on Fri Dec 15 17:15:04 GMT 2023 , Edited by admin on Fri Dec 15 17:15:04 GMT 2023
|
PRIMARY | |||
|
121903
Created by
admin on Fri Dec 15 17:15:04 GMT 2023 , Edited by admin on Fri Dec 15 17:15:04 GMT 2023
|
PRIMARY | |||
|
Piquindone
Created by
admin on Fri Dec 15 17:15:04 GMT 2023 , Edited by admin on Fri Dec 15 17:15:04 GMT 2023
|
PRIMARY | |||
|
78541-97-6
Created by
admin on Fri Dec 15 17:15:04 GMT 2023 , Edited by admin on Fri Dec 15 17:15:04 GMT 2023
|
PRIMARY | |||
|
100000082221
Created by
admin on Fri Dec 15 17:15:04 GMT 2023 , Edited by admin on Fri Dec 15 17:15:04 GMT 2023
|
PRIMARY | |||
|
SUB09890MIG
Created by
admin on Fri Dec 15 17:15:04 GMT 2023 , Edited by admin on Fri Dec 15 17:15:04 GMT 2023
|
PRIMARY |
ACTIVE MOIETY
SALT/SOLVATE (PARENT)